AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 28/02/2011
PIL Betaloc I.V. Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/01/2010 and displayed until 28/02/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 09/06/2008 and displayed until 05/01/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 03/05/2007 and displayed until 09/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change from BAN to rINN
Updated on 12/08/2005 and displayed until 03/05/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/09/2002 and displayed until 12/08/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   metoprolol tartrate